Hagins D, Berhe M, Crofoot GE, Ramgopal MN, et al. Final efficacy and safety of twice-yearly subcutaneous lenacapavir in treatment-naive people with HIV: randomized study. AIDS 2025 Oct 7. doi: 10.1097/QAD.0000000000004372.
PMID: 41056006